The feasibility and acceptability of a pilot randomized controlled trial testing pharmacy-based HPV vaccine completion

Alexis Koskan, Morgan E Zittel, Chong Lee, Omar Sanchez, Linda Alvarez, Deborah L Helitzer, Alexis Koskan, Morgan E Zittel, Chong Lee, Omar Sanchez, Linda Alvarez, Deborah L Helitzer

Abstract

Objective: Immunizing pharmacists can administer vaccines; however, they are less likely to administer adolescent vaccines such as vaccines that protect against human papillomavirus (HPV). Although past research has recommended incorporating pharmacists to increase adolescent vaccination, few intervention studies have tested healthcare delivery models that incorporate pharmacists to aid in vaccine series completion. This research explored the feasibility and acceptability of an intervention in which pharmacists administered booster doses of the HPV vaccine series.

Methods: Between April 2019 and February 2020, the research team recruited participants for a pilot randomized controlled trial hosted in one federally qualified health center (FQHC) clinic. Researchers asked intervention group participants to complete the HPV vaccine series with their community pharmacists and control group participants to complete the series at their FQHC. We conducted a pre- and post-intervention surveys and in-depth interviews with both intervention and control group participants.

Results: A total of 33 parents of children who received the first dose of the HPV vaccine enrolled in the study of whom 8 intervention and 11 control group participants completed post-intervention data collection. Although there were no statistically significant changes in vaccine completion and in psychometric variables, we did find that pharmacist-delivered HPV vaccination was acceptable, due, primarily, to convenience. Barriers to receiving pharmacist-administered vaccines included pharmacies' lack of stocking the vaccine and insurance-related barriers to care.

Conclusion: Although a promising and acceptable healthcare delivery approach, there are still barriers for caregivers to have their children vaccinated against HPV at their community pharmacies.

Keywords: HPV vaccine; Human papillomavirus (HPV); Intervention; Pharmacist; Pharmacy.

Conflict of interest statement

Declaration of competing interest

The authors have no conflicts of interest to report.

Copyright © 2021. Published by Elsevier Inc.

Figures

Fig. 1.
Fig. 1.
Intervention flow diagram.

References

    1. Senkomago V, Henley J, Thomas CC, et al. Human papillomavirus–attributable cancers—United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2019;68(33): 724–728.
    1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–1408.
    1. Arizona State Immunization Information System (ASIIS). HPV Vaccine Coverage. HPV Vaccine Coverage in AZ. 2nd quarter. Phoenix, Arizona: Arizona Department of Health Services; 2020, 2020. Accessed October 10, 2020. Accessed.
    1. Agawu A, Hanlon AL, Buttenheim AM, et al. Disparities in human papillomavirus vaccine series completion by adolescent males: a retrospective cohort study. Acad Pediatr. 2020;20(3):364–373. 10.1016/j.acap.2019.05.002.
    1. Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med. 2019;123:197–203. 10.1016/j.ypmed.2019.03.037.
    1. Ashing KT, Chávez NR, Serrano M. HPV vaccine related knowledge, beliefs, acceptability and uptake among English language preferred and Spanish language preferred Latinas. J Health Commun. 2016;21(12):1209–1216. 10.1080/10810730.2016.1240266.
    1. Yoo W, Koskan A, Scotch M, et al. Patterns and disparities in human papillomavirus (HPV) vaccine uptake for young female adolescents among US states: NIS-Teen (2008–2016). Cancer Epidemiol Biomark Prev. 2020;29(7):1458–1467. 10.1158/1055-9965.EPI-19-1103.
    1. Katz IT, Bogart LM, Fu CM, et al. Barriers to HPV immunization among Blacks and Latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Publ Health. 2016;16:874. 10.1186/s12889-016-3529-4.
    1. Mclean HQ, Birchmeier B, Chow B, et al. Health care provider attitudes and barriers regarding human papillomavirus (HPV) vaccination: factors associated with increasing HPV vaccine coverage before and after an intervention program. Open Forum Infect Dis. 2016;3(Suppl 1):718. 10.1093/ofid/ofw172.581.
    1. Preciado M, Hudson SM, Rondinelli J, et al. An in-depth interview study of immunization providers to understand practice patterns, barriers and facilitators for administering the 3-dose HPV vaccine series. J Patient Cent Res Rev. 2015;2:90–91. 10.17294/2330-0698.1084.
    1. Rimer B, Harper H, Witte O. Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer; a Report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute; 2014. . Accessed December 8, 2020. Accessed.
    1. Fava JP, Colleran J, Bignasci F, et al. Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccines Immunother. 2017;13:1844–1855. 10.1080/21645515.2017.1325980.
    1. Hogue MD, Grabenstein JD, Foster SL, et al. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharmaceut Assoc. 2006;46(2):168–182. 10.1331/154434506776180621.
    1. Schmidt CD, Penn MS. Expanding state laws and a growing role for pharmacists in vaccination services. J Am Pharmaceut Assoc. 2017;57(6):661–669. 10.1016/j.japh.2017.07.001.
    1. Hohmeier KC, Randolph DD, Smith CT, et al. A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting. SAGE Open Med. 2017;4:1–5. 10.1177/2050312116682128.
    1. Bach A, Goad J. The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integrated Pharm Res Pract. 2015;4:67–77. 10.2147/IPRP.S63822.
    1. Teeter BS, Mosley C, Thomas JL, et al. Improving HPV vaccination using implementation strategies in community pharmacies: pilot study protocol. Res Soc Adm Pharm. 2020;16(3):336–341. 10.1016/j.sapharm.2019.05.022.
    1. Omecene NE, Patterson JA, Bucheit JD, et al. Implementation of pharmacist-administered pediatric vaccines in the United States: major barriers and potential solutions for the outpatient setting. Pharm Pract. 2019;17(2):1581. 10.18549/pharmpract.2019.2.1581.
    1. Calo WA, Shah PD, Gilkey MB, et al. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five US states. Hum Vaccines Immunother. 2019;15(7–8):1831–1838. 10.1080/21645515.2019.1602433.
    1. Rogers EM. Diffusion of Innovations. New York: The Free Press; 1995.
    1. Shah PD, Marciniak MW, Golden SD, et al. Pharmacies versus doctors’ offices for adolescent vaccination. Vaccine. 2018;36:3453–3459. 10.1016/j.vaccine.2018.04.088.
    1. Gilkey MB, Calo WA, Moss JL, et al. Adolescent Vaccination in Pharmacies Survey; 2015. . Accessed June 22, 2021. Accessed.
    1. Walker TY. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR (Morb Mortal Wkly Rep). 2017;66(33):874–882. 10.15585/mmwr.mm6633a2.
    1. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288. 10.1136/bmj.a288.
    1. Sutton J, Austin Z. Qualitative research: data collection, analysis, and management. Can J Hosp Pharm. 2015;68(3):226–231. 10.4212/cjhp.v68i3.1456.
    1. Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15: 398–405. 10.1111/nhs.12048.
    1. Shah PD, Gilkey MB, Pepper JK, et al. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13(2):235–246. 10.1586/14760584.2013.871204.
    1. Westrick SC, Hohmann LA, McFarland SJ, et al. Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: a qualitative study in Alabama. Papillomavirus Res. 2017;3:24–29. 10.1016/j.pvr.2016.12.003.
    1. Kelly DV, Young S, Phillips L, et al. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can Pharm J. 2014;147(4): 239–247. 10.1177/1715163514535731.
    1. Trogdon JG, Shafer PR, Shah PD, et al. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents? Vaccine. 2016;34(38):4514–4519. 10.1016/j.vaccine.2016.07.056.
    1. Arizona Department of Health Services. Arizona vaccines for children (VFC) program. ; 2020. Accessed December 8, 2020. Accessed.
    1. Centers for Disease Control and Prevention. HHS secretary PREP Act, 3rd declaration impact on the vaccines for children (VFC) program frequently asked questions. ; 2020. Accessed March 22, 2021. Accessed.
    1. US Department of Health and Humans Services. Third amendment to declaration under the public readiness and emergency preparedness Act for medical countermeasures against COVID–19. Public Law 109–148, Division C, Section 319F–3. 2020;85(164):52136–52141. . Accessed February 18, 2021. Accessed.
    1. Sussman AL, Helitzer D, Bennett A, et al. Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med. 2015;13(4):354–360. 10.1370/afm.1821.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner